ArticleVaccines2022

Declining Epstein-Barr Virus Antibody Prevalence in College Freshmen Strengthens the Rationale for a Prophylactic EBV Vaccine.

Henry H Balfour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.